SPIEGEL Interview with Craig Venter: 'We Have Learned Nothing from the Genome'
Part 2: 'We Couldn't Even Be Certain from my Genome What My Eye Color Was'
The world's first bacteria with a synthetic genome was even coded with an e-mail address.
SPIEGEL: And what about the fears about the abuse of gene data through insurers or employers, for example? Do you see that as sheer hysteria?
SPIEGEL: How much would you be able to learn about us by doing so?
Venter: If anything, we don't really know how to read the genome and it can't tell us very much right now. So what's the ethical debate about?
SPIEGEL: The decoding of your personal genome has so far revealed little more than the fact that your ear wax tends to be moist.
Venter: That's what you say. And what else have I learned from my genome? Very little. We couldn't even be certain from my genome what my eye color was. Isn't that sad? Everyone was looking for miracle 'yes/no' answers in the genome. "Yes, you'll have cancer." Or "No, you won't have cancer." But that's just not the way it is.
SPIEGEL: So the Human Genome Project has had very little medical benefits so far?
Venter: Close to zero to put it precisely.
SPIEGEL: Did it at least provide us with some new knowledge?
Venter: It certainly has. Eleven years ago, we didn't even know how many genes humans have. Many estimated that number at 100,000, and some went as high as 300,000. We made a lot of enemies when we claimed that there appeared to be considerably fewer -- probably closer to the neighborhood of 40,000! And then we found out that there are only half as many. I was just in Stockholm for the 200th anniversary of the Karolinska Institute. The first presentation was about the many achievements the decoding of the genome has brought. Then I spoke and said that this century will be remembered for how little, and not how much, happened in this field.
SPIEGEL: Why is it taking so long for the results of genome research to be applied in medicine?
Venter: Because we have, in truth, learned nothing from the genome other than probabilities. How does a 1 or 3 percent increased risk for something translate into the clinic? It is useless information.
SPIEGEL: There are hundreds of hereditary diseases that can be traced to defects in individual genes. You can determine a lot more than just probabilities through them. But that still hasn't led to a flood of new treatments.
Venter: There were false expectations. Take Ataxia telangiectasia, for example, a horrible disease. The nervous system degenerates, and people who have it often die in their early teens. The cause is a defect in a single gene, but it is a developmental gene. If your body is built in the wrong way, then you can't just take a magic pill to rebuild it. If your brain is wired wrong, then it is wired wrong.
SPIEGEL: Who is to blame for those false expectations?
Venter: We were simply always looking at single genes because they were the only genes we had. When people lose their keys at night, they look under the lamp post. Why? Because that's where you can still see something.
SPIEGEL: But the keys are really located in the dark?
Venter: Exactly. Why did people think there were so many human genes? It's because they thought there was going to be one gene for each human trait. And if you want to cure greed, you change the greed gene, right? Or the envy gene, which is probably far more dangerous. But it turns out that we're pretty complex. If you want to find out why someone gets Alzheimer's or cancer, then it is not enough to look at one gene. To do so, we have to have the whole picture. It's like saying you want to explore Valencia and the only thing you can see is this table. You see a little rust, but that tells you nothing about Valencia other than that the air is maybe salty. That's where we are with the genome. We know nothing.
SPIEGEL: Do you think there will be a time when you can extract all this information to yield real medical results?
Venter: For that to happen we need a lot more information: Information about your body's chemistry, your physiology, your complete medical history, your brain and your entire life. We would need to do that a million times on different people and correlate that data with their genetic information.
SPIEGEL: Will that lead in the end to the kind of personalized medicine that genetic researchers have always touted? Each person would get his or her own personal treatment that is tailored precisely to that person's genetic make-up?
Venter: That was another one of these silly naïve notions that was out there. It's not, 'Oh, we know your genome, we're going to make this drug for you.' That will never happen. It is more important that you use the information in the genome about your personal risks and reduce them through intelligent behavior.
SPIEGEL: You have complained about how naïve genome researchers were in the beginning. Will future generations eventually make fun of us in the same way for how naïve we still are today?
Venter: Only time will tell. Nevertheless, we now have what is going to be one of the most important tools for interpreting the human genome: the first synthetic cell. It will enable us to ask questions that would have been inaccessible before.
SPIEGEL: When no progress was made through the reading of the genome, you shifted to rewriting it. You sequenced the entire genome of a bacteria and used it in another cell. How is the microbe you created doing today?
SPIEGEL: You stored a code in the genome of this cell. Has anyone decoded it?
Venter: Yes, it is the first genome in the world to include an e-mail address. So far, 50 scientists have cracked the code and answered us.
- Part 1: 'We Have Learned Nothing from the Genome'
- Part 2: 'We Couldn't Even Be Certain from my Genome What My Eye Color Was'
- Part 3: 'We Don't Need Any More Neanderthals on the Planet'
© SPIEGEL ONLINE 2010
All Rights Reserved
Reproduction only allowed with the permission of SPIEGELnet GmbH
Ten years ago, Craig Venter had plenty of reason to feel triumphant. Standing at the White House together with his rival Francis Collins of the National Institutes of Health as well as then-President Bill Clinton and former British Prime Minister Tony Blair, he announced the successful sequencing of the human genome. The historic press conference marked the end of a bitter race between Venter's firm Celera and the Human Genome Project, a government-sponsored consortium of around 1,000 scientists from around the world. Both groups had technically mapped the genome, but Venter's team had done it faster and cheaper. Since then, multimillionaire Venter, 63, has established a reputation within the scientific community for being a rebel. It's an image he appears to relish, and he stuns the world again and again with one brash victory after another. He is currently sailing around the world in his Sorcerer II research yacht documenting the genetic diversity of the world's oceans. He recently departed Valencia, Spain, to begin an expedition in the Mediterranean Sea. In May, he announced that his team had produced the world's first bacteria with a synthetic genome.